Picture of DSM-Firmenich AG logo

DSFIR — DSM-Firmenich AG News Story

0.000.00%
nl flag iconLast trade - 00:00
IndustrialsBalancedLarge Cap

Dsm-firmenich reports Q4 core profit miss

Feb 12 (Reuters) - European chemicals maker dsm-firmenich DSFIR.AS reported fourth-quarter core earnings below market expectations on Thursday, days after it agreed the long-awaited sale of its animal health and nutrition unit.

The group's adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) were 478 million euros ($567 million) in the quarter, including discontinued operations from the previously combined businesses. That fell short of analysts' forecast of 488 million euros, a company-provided consensus showed.

($1 = 0.8429 euros)

(Reporting by Dimitri Rhodes in Gdansk, editing by Milla Nissi-Prussak)

((Dimitri.Rhodes@thomsonreuters.com ))

Recent news on DSM-Firmenich AG

See all news